New platform module automates previous manual vaccine design processes, improving quality and dramatically reducing time and resource requirementsAI-Immunology™, already superior...
DELRAY BEACH, Fla., Oct. 7, 2025 /PRNewswire/ -- The global Veterinary Software Market, valued at US$1.44 billion in 2024, stood...
EXECUTIVE CHAIRMAN & CEO OF MEDICUS TO PARTICIPATE IN A PANEL DISCUSSIONThe Summit theme "unlocking the $1 Trillion Wealth transfer...
The DECLARATION (safety and efficacy vs. placebo) and LIBERTY (exploratory safety head-to-head and combination with mRNA-based COVID vaccination) clinical trials...
More than a third of Medicare Advantage and Part D plan enrollees are unaware that significant plan changes are expected...
Secure, scalable, multi-cloud platform using federated learning aims to accelerate cancer discoveries and treatments SEATTLE, WASHINGTON / ACCESS Newswire /...
KINGSTON, N.Y., Sept. 30, 2025 /PRNewswire/ -- Artemis Capital Partners ("Artemis"), a Boston-based private equity firm focused exclusively on partnering...
In this free webinar, gain insight into applying FDA and EMA safety and toxicity grading guidance to keep eCOA data...
AUSTIN, Texas, Sept. 30, 2025 /PRNewswire/ -- Oracle has been recognized as a leader in the 2025 IDC MarketScape: Worldwide Life...
Broad-spectrum Antiviral NV-387 At Phase II Clinical Trial Stage - NV-387 Could Become a Revolutionary Antiviral for Respiratory Viral Infections...
Broad-spectrum Antiviral NV-387 At Phase II Clinical Trial Stage - NV-387 Could Become a Revolutionary Antiviral for Respiratory Viral Infections...
Clinical operations, regulatory affairs, technical expertise, and corporate leadership additions support advancing gene therapy pipeline for cardiovascular diseasesBOSTON, Sept. 30,...
CAMPBELL, Calif., Sept. 29, 2025 /PRNewswire/ -- Saama, an established leader in AI-driven solutions and services within Health Sciences, is introducing...
BEIJING, Sept. 29, 2025 /PRNewswire/ -- METiS TechBio, a pioneer in AI-powered nano-delivery innovation, announced the official launch of NanoForge, the...
ZURICH, SWITZERLAND / ACCESS Newswire / September 29, 2025 / Healthcare AI startup dHealth Intelligence just unveiled an AI agent...
The FDA agrees that the Company may follow 505(b)(2) regulatory pathway to non-invasively treat basal cell carcinoma (BCC) of the...
NEW YORK CITY, NY / ACCESS Newswire / September 26, 2025 / African Heads of State and Government convened global...
FORT LAUDERDALE, Fla., Sept. 26, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII),...
HYDERABAD, India, Sept. 26, 2025 /PRNewswire/ -- According to a recent report by Mordor Intelligence, the medical drones market size...
FDA and Capricor aligned on endpoints for HOPE-3 pivotal trialHOPE-3 pivotal trial completed; topline data expected mid-Q4 2025 to support...